info@tccgroupinternational.com
+225 0777611553

KEY ASSISTANCE- TURKEY, which signed a cooperation agreement with SUNU SİGORTA on 8 November 2022 to facilitate the medical care of patients from Africa abroad, is pleased to work with SUNU SİGORTA, which has the capacity to transfer patients from 17 African countries (Togo, Benin, Burkina Faso, Cameroon, Central Africa, Ivory Coast, Democratic Congo, Republic of Congo, Gabon, Ghana, Guinea, Liberia, Mali, Mauritania, Niger, Nigeria and Senegal).

The aim of this cooperation is to facilitate making appointments, obtaining visas, reducing the cost of medical expenses and evacuating African patients to Turkey for better treatment. For this purpose, an agreement was reached in Libreville with our KEY ASSISTANCE Gabon representative Mr. RogerChristianEpembia, who will act with the coordination of the two centres located in Gabon SUNU and Togo SUNU, with the participation of SUNU Health Insurance Chief GuibétranEricel IPEDISSY and SUNU technical department chief Paul WilfiriedELLA and Turkey KEY ASSISTANCE French-speaking countries director Mr. Murat İşözen and the agreement was signed with the headquarters Togo SUNU.

Our principle of working with SUNU SİGORTA is based on the principle of “Win-Win” which will satisfy everyone in the agreement we have made with the strength we receive from all our partner hospitals.

Comments

  1. I don’t think the title of your article matches the content lol. Just kidding, mainly because I had some doubts after reading the article.

  2. أنابيب الرصاص في العراق تُعرف مصنع إيليت بايب كمزود موثوق لأنابيب الرصاص في العراق. على الرغم من الانخفاض في استخدام أنابيب الرصاص في التطبيقات الحديثة بسبب المخاوف الصحية، تحافظ مصنع إيليت بايب على إرثها في توفير أنابيب رصاص عالية الجودة للتطبيقات المحددة التي لا تزال تحتاج إليها. يضمن التزامنا بالموثوقية والتميز أننا نقدم منتجات تلبي أعلى معايير الأداء. للحصول على معلومات حول أنابيب الرصاص لدينا وتطبيقاتها، قم بزيارة موقعنا الإلكتروني على ElitePipe Iraq.

  3. Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.

Leave a Reply

Your email address will not be published. Required fields are marked *